Guo Chang Jiang, Lai Jian Ping, Luo Hong Mei, Douglas Steven D, Ho Wen Zhe
Division of Immunologic and Infectious Diseases, Joseph Stokes Jr. Research Institute of The Children's Hospital of Philadelphia, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
J Neuroimmunol. 2002 Oct;131(1-2):160-7. doi: 10.1016/s0165-5728(02)00277-1.
Substance P (SP) is an important modulator of neuroimmunoregulation. We have demonstrated that human T lymphocytes express SP and neurokinin-1 receptor (NK-1R), a primary SP receptor. In the present study, we investigated whether SP stimulates synthesis of macrophage inflammatory protein-1beta (MIP-1beta) in human T lymphocytes. SP significantly enhanced MIP-1beta expression at both the mRNA and protein level in a human T cell line (Jurkat) containing the SP receptor gene (J-SPR) as determined by real-time PCR and ELISA assays. SP-induced MIP-1beta expression is abrogated by the specific NK-1R antagonist (CP-96,345). The supernatants from SP-stimulated J-SPR T cell cultures enhanced T lymphocyte chemotaxis in vitro, indicating functional activity of SP-induced MIP-1beta. In addition, SP augmented secretion of MIP-1beta from primary cultures of peripheral blood lymphocytes (PBL) isolated from some of the donors. This donor variability was due to differential expression of the primary SP receptor (NK-1R) on PBL from different donors. PBL from two of seven donors that did not respond to SP stimulation had undetectable NK-1R expression. Our mechanistic studies showed that SP activated NF-kappaB promoter-directed luciferase activity, which may be responsible for its effect on MIP-1beta expression in human T cells. Our data provide a potential mechanism by which SP selectively influences cellular immune responses such as beta-chemokine expression in human T lymphocytes through NK-1R, which may have an important in vivo implication in inflammatory diseases.
P物质(SP)是神经免疫调节的重要调节剂。我们已经证明人类T淋巴细胞表达SP和神经激肽-1受体(NK-1R),后者是SP的主要受体。在本研究中,我们调查了SP是否刺激人类T淋巴细胞中巨噬细胞炎性蛋白-1β(MIP-1β)的合成。通过实时PCR和ELISA分析确定,在含有SP受体基因(J-SPR)的人类T细胞系(Jurkat)中,SP在mRNA和蛋白质水平上均显著增强了MIP-1β的表达。SP诱导的MIP-1β表达被特异性NK-1R拮抗剂(CP-96,345)消除。来自SP刺激的J-SPR T细胞培养物的上清液在体外增强了T淋巴细胞的趋化性,表明SP诱导的MIP-1β具有功能活性。此外,SP增加了从一些供体分离的外周血淋巴细胞(PBL)原代培养物中MIP-1β的分泌。这种供体差异是由于不同供体的PBL上初级SP受体(NK-1R)的表达不同。来自七个供体中的两个对SP刺激无反应的PBL检测不到NK-1R的表达。我们的机制研究表明,SP激活了NF-κB启动子指导的荧光素酶活性,这可能是其对人类T细胞中MIP-1β表达产生影响的原因。我们的数据提供了一种潜在机制,通过该机制SP可通过NK-1R选择性地影响细胞免疫反应,如人类T淋巴细胞中的β-趋化因子表达,这可能在炎症性疾病中具有重要的体内意义。